NDC 0068-0597

Rifadin IV

Rifampin

Rifadin IV is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Rifampin.

Product ID0068-0597_00ecaf45-5dc2-4d5b-9436-ed8ebf4b7170
NDC0068-0597
Product TypeHuman Prescription Drug
Proprietary NameRifadin IV
Generic NameRifampin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date1989-05-25
Marketing CategoryNDA / NDA
Application NumberNDA050627
Labeler NameSanofi-Aventis U.S. LLC
Substance NameRIFAMPIN
Active Ingredient Strength600 mg/10mL
Pharm ClassesRifamycin Antibacterial [EPC], Rifamycins [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0068-0597-01

1 VIAL, GLASS in 1 CARTON (0068-0597-01) > 10 mL in 1 VIAL, GLASS
Marketing Start Date1989-05-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0068-0597-01 [00068059701]

Rifadin IV INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA050627
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1989-05-25

Drug Details

Active Ingredients

IngredientStrength
RIFAMPIN600 mg/10mL

OpenFDA Data

SPL SET ID:036ab68e-5085-4edc-bd83-784b43d64eab
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 198202
  • 198201
  • 201868
  • 207436
  • 312821
  • 201867
  • UPC Code
  • 0300680508606
  • Pharmacological Class

    • Rifamycin Antibacterial [EPC]
    • Rifamycins [CS]

    NDC Crossover Matching brand name "Rifadin IV" or generic name "Rifampin"

    NDCBrand NameGeneric Name
    0068-0597Rifadin IVrifampin
    0068-0508Rifadinrifampin
    0068-0510Rifadinrifampin
    0068-0599Rifadin IV NOVAPLUSrifampin
    0143-9230RifampinRifampin
    0185-0799RifampinRifampin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.